Journal of Antimicrobial Chemotherapy, Vol 41, 215-221, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy
LB Quesnel, AS Jaran and JM Braganza
Cystic fibrosis (CF) results from mutations in the gene encoding the CF
transmembrane conductance regulator (CFTR) which is a regulated chloride
channel. The deltaF508 mutation prevents the post- translational
glycosylation and membrane insertion of the protein. Severe disease
follows, with the formation of a viscous mucus and subsequent chronic
bacterial infection of the lungs, necessitating frequent, and often long,
periods of antibiotic treatment. The pharmacokinetics of antibiotics in CF
patients are abnormal, with lower blood serum levels and higher clearance
rates which have never been satisfactorily explained. We found that
accumulation of gentamicin in nasal polyp tissue non-CF cells was subject
to regulation by the effectors and inhibitors of CFTR function; regulation
was lost in deltaF508 CF cells and accumulation was more than doubled
because of the inhibition of exocytosis.
ORIGINAL ARTICLES
Antibiotic accumulation and membrane trafficking in cystic fibrosis cells
School of Biological Sciences, University of Manchester, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Sharer, M. Schwarz, G. Malone, A. Howarth, J. Painter, M. Super, and J. Braganza Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis N. Engl. J. Med., September 3, 1998; 339(10): 645 - 652. [Abstract] [Full Text] [PDF] |
||||
